3-86978565-T-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000398399.7(VGLL3):c.364A>T(p.Ile122Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000229 in 1,614,162 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000398399.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VGLL3 | NM_016206.4 | c.364A>T | p.Ile122Phe | missense_variant | 2/4 | ENST00000398399.7 | NP_057290.2 | |
VGLL3 | NM_001320493.2 | c.364A>T | p.Ile122Phe | missense_variant | 2/4 | NP_001307422.1 | ||
VGLL3 | NM_001320494.2 | c.205A>T | p.Ile69Phe | missense_variant | 2/4 | NP_001307423.1 | ||
VGLL3 | XM_006713138.5 | c.361A>T | p.Ile121Phe | missense_variant | 2/4 | XP_006713201.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VGLL3 | ENST00000398399.7 | c.364A>T | p.Ile122Phe | missense_variant | 2/4 | 1 | NM_016206.4 | ENSP00000381436 | P1 | |
VGLL3 | ENST00000383698.3 | c.364A>T | p.Ile122Phe | missense_variant | 2/4 | 1 | ENSP00000373199 | |||
VGLL3 | ENST00000494229.1 | c.166A>T | p.Ile56Phe | missense_variant | 2/3 | 3 | ENSP00000419115 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152196Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000482 AC: 12AN: 249160Hom.: 0 AF XY: 0.0000740 AC XY: 10AN XY: 135208
GnomAD4 exome AF: 0.0000239 AC: 35AN: 1461848Hom.: 1 Cov.: 31 AF XY: 0.0000358 AC XY: 26AN XY: 727228
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152314Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74480
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 20, 2024 | The c.364A>T (p.I122F) alteration is located in exon 2 (coding exon 2) of the VGLL3 gene. This alteration results from a A to T substitution at nucleotide position 364, causing the isoleucine (I) at amino acid position 122 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at